GSK has announced a $30bn investment in the US over the next five years in research and development (R&D) and supply chain.

President Donald Trump’s state visit to the UK has delivered pledges from US tech giants to invest tens of billions of dollars in the AI sector.The UK and ...

The new projects, including AI efforts in Pennsylvania and three other states, are part of the British firm's pledge to ...

Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure ...

GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug ...

GSK said the spending will help build new biologics facilities and upgrade existing plants in Pennsylvania, North Carolina, ...

GSK to invest $30 billion in R&D and supply chain infrastructure in US over next 5 years: London, UK Thursday, September 18, 2025, 11:00 Hrs [IST] GSK plc announced plans to inves ...

British pharmaceutical firm GSK has pledged to invest $30bn (£22bn) in research and manufacturing in the US over the next ...

President Donald Trump's state visit to the UK has delivered pledges from US tech giants to invest a combined $42 billion to ...

British pharmaceutical giant GlaxoSmithKline (GSK) has announced a massive $30 billion investment in the United States. The ...

The FTSE 100 recovered ground on Wednesday, supported by gains in utilities and housebuilders, even as mining stocks lagged.

GSK and Eli Lilly are the latest to unveil plans to add to manufacturing and increase other operations in America.